Per Odin (P Odin)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 19

Top Topics

Psychometric Properties

Systematic Review

Parkinson Disease

Radical Prostatectomy

Top Venues

Acta neurologica Scandinavica

Parkinson's disease

Movement disorders clinical practice

Brain and behavior

This page only lists publications with an associated author ORCID identifier.

Publications

Jennifer S Pigott, Megan Armstrong, Nathan Davies, Daniel H J Davis, Bastiaan R Bloem, Stefan Lorenzl, Wassillios G Meissner, Per Odin, Joaquim José Ferreira, Richard Dodel, Anette-Eleonore Schrag
Factors associated with self-rated health in people with late-stage parkinson's and cognitive impairment. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation (2024)
Kristina Rosqvist, Per Odin
Compliance with National and International Guidelines in the Treatment of Nonmotor Symptoms in Late-Stage Parkinson's Disease. Parkinson's disease 2023 (2023)
Jenny M Norlin, Klas Kellerborg, Ulf Persson, Daniel Oudin Åstrøm, Peter Hagell, Pablo Martínez-Martín, Per Odin
Clinical Impression of Severity Index for Parkinson's Disease and Its Association to Health-Related Quality of Life. Movement disorders clinical practice 10 (3) (2023)
Gustav Cedergren Weber, Jonathan Timpka, Anna Rydelius, Johan Bengzon, Per Odin
Tumoral parkinsonism-Parkinsonism secondary to brain tumors, paraneoplastic syndromes, intracranial malformations, or oncological intervention, and the effect of dopaminergic treatment. Brain and behavior (2023)
Onanong Phokaewvarangkul, Roongroj Bhidayasiri, Pedro José García-Ruiz, Per Odin, Peter Riederer, Thomas Müller
Homocysteine, vitamin B metabolites, dopamine-substituting compounds, and symptomatology in Parkinson's disease: clinical and therapeutic considerations. Journal of neural transmission (Vienna, Austria : 1996) (2023)
Jenny M Norlin, Klas Kellerborg, Ulf Persson, Daniel Oudin Åstrøm, Peter Hagell, Pablo Martínez-Martín, Per Odin
Clinical Impression of Severity Index for Parkinson's Disease and Its Association to Health-Related Quality of Life. Movement disorders clinical practice 10 (3) (2023)
Angelo Antonini, Rajesh Pahwa, Per Odin, Tove Henriksen, Michael J Soileau, Ramon Rodriguez-Cruz, Stuart H Isaacson, Aristide Merola, Susanna Lindvall, Josefa M M Domingos, Ali Alobaidi, Yash J Jalundhwala, Prasanna L Kandukuri, Juan Carlos Parra, Pavnit K Kukreja, Koray Onuk, Lars Bergmann, James Pike, Kallol Ray Chaudhuri
Psychometric Properties of Clinical Indicators for Identification and Management of Advanced Parkinson's Disease: Real-World Evidence From G7 Countries. Neurology and therapy 11 (1) (2022)
Angelo Antonini, Rajesh Pahwa, Per Odin, Stuart H Isaacson, Aristide Merola, Lin Wang, Prasanna L Kandukuri, Ali Alobaidi, Connie H Yan, Yanjun Bao, Cindy Zadikoff, Juan Carlos Parra, Lars Bergmann, Kallol Ray Chaudhuri
Comparative Effectiveness of Device-Aided Therapies on Quality of Life and Off-Time in Advanced Parkinson's Disease: A Systematic Review and Bayesian Network Meta-analysis. CNS drugs 36 (12) (2022)
Jenny M Norlin, Frida Hjalte, Christopher Kruse, Richard Dodel, Kristina Rosqvist, Per Odin
Quality of life and resource utilization-Swedish data from the Care of Late-Stage Parkinsonism (CLaSP) study. Acta neurologica Scandinavica 145 (6) (2022)
Jenny M Norlin, Klas Kellerborg, Per Odin
Patient Utilities in Health States Based on Hoehn and Yahr and Off-Time in Parkinson's Disease: A Swedish Register-Based Study in 1823 Observations. PharmacoEconomics 39 (10) (2021)
Kristina Rosqvist, Per Odin, Stefan Lorenzl, Wassillios G Meissner, Bastiaan R Bloem, Joaquim José Ferreira, Richard Dodel, Anette-Eleonore Schrag, null null
Factors Associated with Health-Related Quality of Life in Late-Stage Parkinson's Disease. Movement disorders clinical practice 8 (4) (2021)
Jenny M Norlin, Michael Willis, Ulf Persson, Emelie Andersson, Sven E Pålhagen, Per Odin
Swedish guidelines for device-aided therapies in Parkinson's disease -Economic evaluation and implementation. Acta neurologica Scandinavica 144 (2) (2021)
Monica Scharfenort, Jonathan Timpka, Thomas Sahlström, Tove Henriksen, Vincenzo Donadio, Per Odin
Close relationships in Parkinson´s disease patients with device-aided therapy. Brain and behavior 11 (6) (2021)
Kristina Rosqvist, Marianne Kylberg, Charlotte Löfqvist, Anette-Eleonore Schrag, Per Odin, Susanne Iwarsson
Perspectives on Care for Late-Stage Parkinson's Disease. Parkinson's disease 2021 (2021)
Frida Hjalte, Jenny M Norlin, Klas Kellerborg, Per Odin
Parkinson's disease in Sweden-resource use and costs by severity. Acta neurologica Scandinavica 144 (5) (2021)
Claas Ehlers, Jonathan Timpka, Per Odin, Holger Honig
Levodopa infusion in Parkinson's disease: Individual quality of life. Acta neurologica Scandinavica 142 (3) (2020)
Daniel Johannes van Wamelen, Pablo Martínez-Martín, Daniel Weintraub, Anette Schrag, Angelo Antonini, Cristian Falup-Pecurariu, Per Odin, Kallol Ray Chaudhuri, null null
The Non-Motor Symptoms Scale in Parkinson's disease: Validation and use. Acta neurologica Scandinavica 143 (1) (2020)
Kristina Rosqvist, Peter Hagell, Susanne Iwarsson, Maria H Nilsson, Per Odin
Satisfaction with Care in Late Stage Parkinson's Disease. Parkinson's disease 2019 (2019)
Manzur Kader, Stina B Jonasson, Susanne Iwarsson, Per Odin, Maria H Nilsson
Mobility device use in people with Parkinson's disease: A 3-year follow-up study. Acta neurologica Scandinavica 138 (1) (2018)